A Study of MK0653A (Ezetimibe (+) Simvastatin) in Patients With Hypercholesterolemia (0653A-038)

Organon

Status and phase: Completed; Phase 3

Conditions: Hypercholesterolemia

Treatments: Drug: MK0653A, ezetimibe (+) simvastatin; Drug: Comparators: simvastatin and ezetimibe

Study type: Interventional

Funder types: Industry

Identifiers

NCT00092651

0653A-038

2004_048

Details and patient eligibility

About

The purpose of this study is to evaluate the lipid lowering effects of an investigational drug in patients with hypercholesterolemia (high cholesterol).

Full description

The duration of treatment is 4 months.

Enrollment: 1,398 patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• High cholesterol

Exclusion criteria

• Patient has a condition which, in the opinion of the investigator, might pose a risk to the patient, interfere with participation in the study, or does not meet the additional criteria as required by the study.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind